Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Journal: Annals of internal medicine
Published: April 17, 2023
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 10, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Journal: The New England journal of medicine
Published: July 14, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Journal: JAMA
Published: January 21, 2021
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
Journal: The New England journal of medicine
Published: October 28, 2020
Showing 1-5 of 5
Last Updated: 09/26/2026